Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Anthem BiosciencesNSE:ANTHEM -0.93%34 Market Cap is ₹419,965 Mil as of Jul. 14, 2026. GuruFocus rates NSE:ANTHEM with a GF Score™ of 34/100. The stock has 2 warning signs investors should review. Among 1,423 Biotechnology companies, Anthem Biosciences ranks better than 93.46% on this metric.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Anthem Biosciences's share price for the quarter that ended in Mar. 2026 was ₹656.25. Anthem Biosciences's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 562 Mil. Therefore, Anthem Biosciences's market cap for the quarter that ended in Mar. 2026 was ₹368,625 Mil.
Anthem Biosciences's quarterly market cap
declined
from Sep. 2025 (₹427,498 Mil) to Dec. 2025 (₹365,889 Mil) but then
increased
from Dec. 2025 (₹365,889 Mil) to Mar. 2026 (₹368,625 Mil).
Anthem Biosciences's annual market cap
stayed the same
from Mar. 2024 (₹0 Mil) to Mar. 2025 (₹0 Mil) but then
increased
from Mar. 2025 (₹0 Mil) to Mar. 2026 (₹368,625 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Anthem Biosciences's Enterprise Value for Today is ₹411,120 Mil.
Anthem Biosciences (NSE:ANTHEM) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Anthem Biosciences Market Cap Related Terms
Anthem Biosciences Market Cap Historical Data
* Premium members only.
The historical data trend for Anthem Biosciences's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ANTHEM vs VRTX, REGN, ALNY: Market Cap Comparison
For the Biotechnology subindustry, Anthem Biosciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Anthem Biosciences Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Anthem Biosciences's Market Cap distribution charts can be found below:
* The bar in red indicates where Anthem Biosciences's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Anthem Biosciences's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Anthem Biosciences (NSE:ANTHEM) has a Market Cap of ₹419,965 Mil as of Jul. 14, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Anthem Biosciences and its competitors. According to the industry distribution chart, Anthem Biosciences ranks #93 out of 1423 companies in the Biotechnology industry, placing it in the top 6.5%.
Is Anthem Biosciences' Market Cap too high?
Anthem Biosciences' current Market Cap is ₹419,965 Mil. Based on the distribution chart, Anthem Biosciences ranks #93 out of 1423 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Anthem Biosciences has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does Anthem Biosciences' Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Anthem Biosciences ranks #93 out of 1423 companies for Market Cap. This places Anthem Biosciences in the top 7% of its industry — outperforming the majority of peers. The industry median Market Cap is 119.31. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 119.31, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Anthem Biosciences and its competitors. For the Biotechnology industry, the median Market Cap is 119.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Anthem Biosciences's current Market Cap is ₹419,965 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Anthem Biosciences stock overvalued right now?
Anthem Biosciences (NSE:ANTHEM) has a current Market Cap of ₹419,965 Mil. The current Market Cap is ₹419,965 Mil. Anthem Biosciences' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Anthem Biosciences (NSE:ANTHEM), the current Market Cap is ₹419,965 Mil as of Jul. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Anthem Biosciences Ltd is an innovation-driven and technology-focused Contract Research, Development and Manufacturing Organization (CRDMO) with fully integrated operations spanning across drug discovery, development and manufacturing. It is one of the few companies in India with integrated New Chemical Entity (NCE) and New Biological Entity (NBE) capabilities across drug discovery, development, and commercial manufacturing. As a one-stop service provider, It serves a range of customers, encompassing innovator-focused emerging biotech and large pharmaceutical companies globally.
34GF Score
Get the complete analysis for NSE:ANTHEM
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ANTHEM has been successfully added to your 
